Clinical trial
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once…
NCT00378027 · The Cleveland Clinic, Other · Withdrawn
Key facts
| NCT number | NCT00378027 |
|---|---|
| Title | Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux |
| Official title | Phase IV, Single Arm Study to Obtain Information Regarding the Safety and Efficacy of Fondaparinux Given Outpatient for Treatment of Acute Pulmonary Embolism |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Fondaparinux |
| Enrollment | 0 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 19, 2006 |
| Last update posted | Jan 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: